Preventing strongyloidiasis in the immunosuppressed.
Rao
P Narasimha
PN
Kiran
K U
KU
D015766:Albendazole / Q000627:therapeutic use; D000977:Antiparasitic Agents / Q000627:therapeutic use; D015984:Causality; D019353:Endemic Diseases; D006801:Humans; D016867:Immunocompromised Host; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007559:Ivermectin / Q000627:therapeutic use; D013322:Strongyloidiasis / Q000453:epidemiology / Q000517:prevention & control*; D014329:Tropical Climate
D000977:Antiparasitic Agents; D007559:Ivermectin; D015766:Albendazole